Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P
Abstract Background Stereotactic Body Radiotherapy (SBRT) has shown effectiveness in treating bone metastases to alleviate pain. The benefit of SBRT may be further harnessed especially when radiating disease from primary malignancies with low alpha–beta ratios in order to maximize the magnitude and...
Main Authors: | Eric K. Nguyen, Kimmen Quan, Sameer Parpia, Stephan Tran, Anand Swaminath |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-021-01897-0 |
Similar Items
-
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases
by: Sara Lindberg, et al.
Published: (2022-09-01) -
Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer
by: Adam Mutsaers, et al.
Published: (2017-06-01) -
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
by: Fabian Weykamp, et al.
Published: (2022-12-01) -
Robotic Stereotactic Body Radiotherapy for Spine Metastasis Pain Relief
by: Daniel Rivas, et al.
Published: (2024-02-01) -
Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)